Evidence map›Paper›PMID 39623600›Full record

ArticleCancer communications (London, England)2025

Nicotinamide N-methyltransferase negatively regulates metastasis-promoting property of cancer-associated fibroblasts in lung adenocarcinoma.

Peiyu Wang, Guangxi Wang, Haoran Li, Yuyao Yuan, Haiming Chen, Shaodong Wang, Zewen Sun, Fanjie Meng, Yun Li, Fan Yang and 3 more

Abstract read
In one paragraph

Article in Cancer communications (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Molecular mechanisms and therapeutic targets in lung cancer-nerve crosstalk.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. CTHRC1Frontiers in immunology · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Peiyu WangDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, P. R. China.ORCID https://orcid.org/0000-0002-7021-3939
Guangxi WangDepartment of Pathology, School of Basic Medical Sciences, Institute of Systems Biomedicine, Peking-Tsinghua Center for Life Sciences, Peking University Health Science Center, Beijing, P. R. China.
Haoran LiDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, P. R. China.
Yuyao YuanDepartment of Pathology, School of Basic Medical Sciences, Institute of Systems Biomedicine, Peking-Tsinghua Center for Life Sciences, Peking University Health Science Center, Beijing, P. R. China.
Haiming ChenDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, P. R. China.
Shaodong WangDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, P. R. China.
Zewen SunDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, P. R. China.
Fanjie MengDepartment of Thoracic Surgery, Beijing Institute of Respiratory Medicine and Beijing Chao Yang Hospital, Capital Medical University, Beijing, P. R. China.
Yun LiDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, P. R. China.
Fan YangDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, P. R. China.
Jun WangDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, P. R. China.
Kezhong ChenDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, P. R. China.
Mantang QiuDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, P. R. China.ORCID https://orcid.org/0000-0002-0419-9139

Funding

Beijing Nova Program 20230484314Innovation Fund for Excellent PhD student of Peking University Health Science Center 2022-58Medical and Health Science and Technology Innovation project 2021-I2M-002National Key R&D Program of China 2023YFF0723500National Natural Science Foundation of China 82173386National Natural Science Foundation of China 92059203Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences 2021RU002
6 · The paper itself

Abstract

backgroundRecurrence and metastasis remain significant challenges in lung adenocarcinoma (LUAD) after radical resection. The mechanisms behind the recurrence and metastasis of LUAD remain elusive, and deregulated cellular metabolism is suspected to play a significant role. This study explores the metabolic and epigenetic regulation mediated by nicotinamide N-methyl transferase (NNMT) in LUAD.

methodsUntargeted metabolomic analyses were performed to detect metabolism irregularities. Single-cell RNA sequencing (RNA-seq) databases and multiplex immunofluorescence analysis were used to identify the location of NNMT within the tumor microenvironment. The biological functions of NNMT were investigated both in vitro and in vivo, with RNA-seq and chromatin immunoprecipitation-PCR providing insights into underlying mechanisms. Finally, single-cell RNA-seq data and immunohistochemistry of primary tumors were analyzed to validate the main findings.

resultsUntargeted metabolomic analyses revealed metabolic aberrations in amino acids, organic acids, lipids, and nicotinamide pathways, which are linked to metastasis of non-small cell lung cancer. NNMT is a key enzyme in nicotinamide metabolism, and we found the bulk tissue mRNA level of NNMT gene was inversely associated with LUAD metastasis. NNMT was proved to be predominantly expressed in cancer-associated fibroblasts (CAFs) within the stromal regions of LUAD, and a low stromal NNMT expression was identified as a predictor of poor disease-free survival following radical resection of LUAD. The isolation and primary culture of CAFs from LUAD enabled in vitro and in vivo experiments, which confirmed that NNMT negatively regulated the metastasis-promoting properties of CAFs in LUAD. Mechanistically, the downregulation of NNMT led to an increase in intracellular methyl groups by reducing the activity of the methionine cycle, resulting in heightened methylation at H3K4me3. This alteration triggered the upregulation of genes involved in extracellular matrix remodeling in CAFs, including those encoding collagens, integrins, laminins, and matrix metalloproteinases, thereby facilitating cancer cell invasion and metastasis. Reanalysis of single-cell RNA-seq data and immunohistochemistry assays of primary LUAD tissues substantiated NNMT's negative regulation of these genes in CAFs.

conclusionsThis study provides novel insights into the metabolic and epigenetic regulatory functions of NNMT in CAFs, expanding the current understanding of LUAD metastasis regulation and suggesting potential avenues for future research and therapeutic development.

Indexed as

Adenocarcinoma of LungCancer-Associated FibroblastsLung NeoplasmsNicotinamide N-MethyltransferaseAnimalsCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansMaleMetabolomicsMiceNeoplasm MetastasisTumor MicroenvironmentNicotinamide N-MethyltransferaseNNMT protein, humanCancer‐associated fibroblastExtracellular matrixLung cancerMetastasisNicotinamide N‐methyl transferase

Identifiers

PMID39623600
PMCPMC11833673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.